Characteristics of human gastric carcinoma cell lines with induced multidrug resistance

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3531-3536

  Kang, Myung Soo ^a   Kim, Hun Sik ^b   Han, Jeong A ^c   Park, Sang Chul ^c   Kim, Won Bae ^d   Park, Jae Gahb ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Dong A Pharmaceutical Company   (South Korea)

Author keywords

Doxorubicin; Gastric carcinoma; Multidrug resistance; P glycoprotein p21(WAF1); Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN P21; PROTEIN P53; RNA; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG TRANSPORT; DRUG UPTAKE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STOMACH CARCINOMA;

BIOLOGICAL TRANSPORT; CARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030731516     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Moscow JA, Cowan KH: Multidrug resistance. J Natl Cancer Inst 80: 14-20, 1988
2. Metha K: High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 58: 400-406, 1994.
3. Cowan KH, Batist G, Tulpule A, Sinha BK, and Myers CE.: Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci USA 83: 9328-9332, 1986.
4. Chu TM, Lin TH, Kawinski E: Detection of soluble P glycoprotein in culture media and extracellular fluids. Biochem Biophys Res Commun 203: 506-512, 1994.
5. Deffie AM, Bosman DJ, Goldenberg GJ: Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin resistant P388 murine leukemia cells. Cancer Res 49: 6879-6882, 1989.
6. Fanciulli M, Bruno T, Castiglione S: Glucose metabolism in adriamycin sensitive and resistant LoVo human colon carcinoma cells. Oncol Res 5: 357-362, 1993.
7. Baas F, Jongsma AP, Broxterman HJ: Non P glycoprotein mediated mechanism for multidrug resistance precedes P glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res 50: 5392-5398, 1990.
8. Morre DJ, Morre DM, Wu LY: Response to adriamycin of transplasma membrane electron transport in adriamycin resistant and nonresistant HL 60 cells. J Bioenerg Biomembr 26: 137-142, 1994.
9. Park JG, Frucht H, Larocca RV, Bliss DP Jr, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Jhonson BE, Bang YJ, Kim JP And Gazdar AF: Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50: 2773-2780, 1990.
10. Park JG, Kramer BS, Lai SL, Goldstein LJ And Gazdar AF: Chemosensitivity patterns and expression of human multidrug resistance associated MDR1 gene by human gastric and colorectal cancer lines. J Natl Cancer Inst 82: 193-198, 1990.
11. Tanaka S, Aizawa K, Katayanagi N, And Tanaka O: Flow cytometric analysis of early steps in development of adriamycin resistance in a human gastric cancer cell line. Jpn Cancer Res 85: 86-92, 1994.
12. Park JG, Oie HK, Sugarbaker PH, Henslee JG, Chen TR, Johnson BE And Gazdar A: Characteristics of cell lines established from human colorectal carcinomas. Cancer Res 47: 6710-6718, 1987.
13. Gros P, Croop J, Housman D: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport protein. Cell 47: 371-380, 1986.
14. Tsai-Pflugfelder M, Liu LF, Liu AA, Tewey KM, Wang-Peng J, Knutsen T, Huebner K, Croce CM and Wang JC: Cloning and sequecncing of cDNA encoding human DNA topoisomerase II and localization of the gene to human chromosome 17q21-22. Proc Natl Acad Sci USA. 7177-7181, 1988.
15. El Diery, WS, Tokino T, Velculesco VE, Levy DB, Parson R, Trent JM, Lin D, Mercer EW, Kinzler KW and Vogelstein B: WAF1, A potential mediator of p53 iumor suppression. Cell 75: 817-825, 1993.
16. Kunimoto S, Minura K, Takahashi Y, Takeuchi T and Umezawa H. Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O tetrahydropyranyladriamycin. J. Antibiot Tokyo 36: 312, 1983.
17. Kunimoto S, Minura K, Umezawa K, Xu CZ, Masuda T, Takeuchi T and Umezawa H: Cellular uptake and efflux and cytostatic activity of 4'-O tetrahydropyranyladriamycin in adryamycin-sensitive and resistant tumor cell lines. J. Antibiot Tokyo 37: 1697, 1984.
18. Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity. Cancer Res 47: 943-946, 1987.
19. Sambrook J, Fritisch EF, Maniatis T: Molecular cloning: a laboratory manual, 2nd Ed., Cold Spring Harbor; Cold Spring Harbor Press, 1989.
20. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and Deeley RG: Overexpression of a transport gene in a multidrug resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
21. Deffie Am, Batra JK, Goldenberg GJ: Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin sensitive and -resistant P388 leukemia cell lines. Cancer Res 49: 58-62, 1989.
22. Liu LF, Davis JL, Calender R: Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerase. Nucleic Acids Res 9: 3979-3989, 1981.
23. Halligan BD, Edwards KA And Liu LF: Purification and characterization of a type II DNA topoisomerase from bovine calf thymus. J Biol Chem 260: 2475-2482, 1985.
24. Kruh GD, Gaughan KT, Godwin A and Chan A: Expression pattern of MRP in human tissues and adult solid tumor cell lines. J Natl Cancer Inst 87: 256-258, 1995.
25. Batist G, Tulpule A, Sinha BK, Katki AG, Meyers CE, and Cowan KH: Overexpression of a novel anionic glutathione transferase in multidrug resistant human breast cancer cells. J Biol Chem 261: 15544-15549, 1986.
26. Kodera Y, Akiyama S, Isohe K, Kondo K, Yamauchi M, Takagi H: Expression of pi-glutathione S transferase in gastric cancer: lack of correlation with resistance against cis-diamminedchloroplatinum (II). Eur J Cancer 30A: 2158-2162, 1994.
27. Okuyama T, Maehara Y, Endo K, Baba H, Adachi Y, Kuwano M, Sugimachi K: Expression of glutathione S transferase pi and sensitivity of human gastric cancer cells to cisplatin. Cancer 15: 1230-1236, 1994.
28. Kodera Y, Isobe K, Yamauchi M, Kondo K, Akiyama S, Ito K, Nakashima I, Takagi H: Expression of glutathione S transferase alpha and pi in gastric cancer: a correlation with cisplatin resistance. Cancer Chemother Pharmacol 34: 203-208, 1994.
29. Ciocca DR, Fugua SA, Lock-Lim S, Toft DO, Welch WJ and Mcguire WL: Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52: 3648-36542, 1992.
30. Osterreich S, Weng CN, Qui M, Hilsenbeck SG, Osborne CK, Fugua SA: The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 53: 4443-4448, 1993.
31. Pommier Y, Kerrigan D, Schwartz RE, Swack JA, Mccurdy A: Altered topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitor. Cancer Res 46: 3075-3081, 1986.
32. Sinha BK, Haim N, Durse L, Kerrigan D, Pommier Y: DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action. Cancer Res 48: 5096-5100, 1988.
33. Eder JP, Chan VTW, Ng Sw, Rizvi NA, Zachaloulis S, Teicher BA and Schnipper LE: DNA topoisomerase IIa expression is associated with alkylating agent resistance. Cancer Res 55: 6109-6116, 1995.
34. DeJong S, Zilstra JG, Mulder NH, and De Varies EGE: Lack of cross resistance to fostreicin in a human small cell carcinoma cell line showing topoisomerase IIrelated drug resistance. Cancer Chemother. Pharmacol 28: 461-464, 1991.
35. Tan KB, Mattern MR, Boyce RA, and Schein PS: Elevated DNA topoisomerase II activity in a nitrogen mustard resistant human cells. Proc. Natl. Acad. Sci. USA 84: 7668-7671, 1987.
36. Nagai S, Yamauchi M, Andoh T, Nishizawa M, Satta T, Kodera Y, Kondou K, Akiyama S, Ito K and Takagi H: Establishment and characterization of human gastric and colonie xenograft lines resistant to CPT-11 (a new derivative of camptothecin). J Surg Oncol 59: 116-124, 1995.
37. Hinds M, Deisseroth K, Mayes J, Altschuler E, Jansen R, Ledley FD and Zwelling LA: Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoismerase II. Cancer Res 51: 4729-4731, 1991.
38. WAF1/cip1 level. Cancer Lett 108: 15 23, 1996.